Category: Emerald Conference

  • Increasing the Varieties of Marijuana and Marijuana products for Research

    Increasing the Varieties of Marijuana and Marijuana products for Research

    The CESC is a non-profit organization with a mission to align Cannabis science, clinical practice, and public policy to ensure best outcomes. Our initial observation of the marijuana varieties used in states with medical cannabis laws noted higher levels of THC and CBD than the varieties available in the marijuana plant material of the NIDA… Read more

  • Radicle Aces (Advancing CBD Education & Science)

    Radicle Aces (Advancing CBD Education & Science)

    Radicle ACES is the first multi-brand, Institutional Review Board-approved randomized controlled trial to evaluate the effectiveness of commercially available CBD products. We recruited 3000 participants from across the United States who reported symptoms of anxiety, sleep disturbance, or long-term pain, and randomized them to receive a 4-week supply of 1 of 13 different commercially available… Read more

  • Artificial Intelligence For Craft Cannabis

    Artificial Intelligence For Craft Cannabis
    ,

     Extraction artists need help. While Big Data is nearly everywhere in the cannabis industry, extraction is still stuck in the last century. However, Artificial Intelligence is not the Savior of all. Data by itself is meaningless, incomplete, and devoid of solutions.  Read more

  • Solving Cannabis Consistency

    Solving Cannabis Consistency
    ,

    The cannabis edibles and THC beverage industries struggle with consistency and bioavailability problems.This paper outlines the real and measurable benefits of using nanoemulsions in the newly growing ediblemarketplace. It examines the pharmacokinetic testing data, science, and research behind the latest advances innanoemulsion technology and explores how nanoemulsions can provide greater bioavailability and improvedconsistency for hemp… Read more

  • Case Study: Metastatic Breast Cancer In Remission

    Case Study: Metastatic Breast Cancer In Remission
    ,

    A 49-year-old woman was diagnosed with an ER+, PR-, HER2+, BRCA- De Novo metastatic breast cancer including bone, liver, and lymph node involvement. Standardized care included a five-month treatment period with targeted chemotherapy and radiotherapy, and a ketogenic diet. The patient also began a course of whole plant cannabinoid-based therapy and psilocybin-assisted psychotherapy at macro… Read more